Estrogen and Progesterone Receptors in Benign Ovarian Tumors of Menopausal Breast Cancer Patients Treated with Tamoxifen

Publisher： Karger

E-ISSN： 1423-002x|46|2|116-122

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.46, Iss.2, 1998-08, pp. : 116-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen and Progesterone Receptors of Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

By  

Gynecologic and Obstetric Investigation, Vol. 45, Iss. 2, 1998-02 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

Potential Role of β1 Integrin and Collagen Biosynthesis in Estrogen-Dependent Reduction of Apoptosis in Tamoxifen-Treated Breast Cancer Cells

By  

Gynecologic and Obstetric Investigation, Vol. 51, Iss. 4, 2001-06 ,pp. : 248-253

Karger

Access to resources Recommend Favorite

Different Coexisting Gynecological and Endometrial Pathologies in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

By  

Gynecologic and Obstetric Investigation, Vol. 46, Iss. 2, 1998-08 ,pp. : 123-129

Karger

Access to resources Recommend Favorite

Differential Diagnosis of Smooth Muscle Tumors Utilizing p53, pTEN and Ki-67 Expression with Estrogen and Progesterone Receptors

By  

Gynecologic and Obstetric Investigation, Vol. 59, Iss. 1, 2005-01 ,pp. : 36-40

Karger

Access to resources Recommend Favorite

Serum and Tissue LDH Levels in Patients with Breast/Gynaecological Cancer and Benign Diseases

By  

Gynecologic and Obstetric Investigation, Vol. 67, Iss. 3, 2008-12 ,pp. : 162-168

Karger

Access to resources Recommend Favorite